Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease and considerable long-term toxicities of treatment. Since clinical risk factors lack ...
M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors
Cerebrospinal fluid (CSF) liquid biopsies serve as a rich source of tumor-derived cell-free DNA (cfDNA) for evaluating persons with central nervous system (CNS) tumors. However, challenges stemming ...
Select Agents (SAs) are listed dangerous bacteria, viruses, toxins, and fungi. However, natural variation and intentional genetic modification blur the boundaries of a Select Agent list based on names ...
The article by Heger et al entitled “Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma” (J Clin Oncol 10.1200/JCO.23 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results